The serum IL-17A levels were significantly increased in patients with SLE who harboured GLK germline or somatic variants compared with those of HCs in Cohort #1 (online supplemental figure S6), while IL-17A levels were modestly increased in patients with SLE without GLK variants (online supplemental figure S6). Here, MAP4K3 is linked to systemic lupus erythematosus.